ArticleFrontiers in medicine2026
Postoperative breast function and quality of life follow-up study in patients with plasma cell mastitis: a 1-year longitudinal analysis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent Advances in Pathogenesis, Diagnosis and Integrated Traditional Chinese Medicine Therapy for Plasma Cell Mastitis.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasma cell mastitis (PCM) is a chronic inflammatory breast disease requiring surgical intervention, yet postoperative functional outcomes and quality of life remain poorly characterized. This study evaluated longitudinal changes in breast function and health-related quality of life following surgical treatment for PCM. This retrospective longitudinal cohort study included 142 women with histologically confirmed PCM who underwent surgical treatment between January 2020 and December 2023. Patients were assessed at baseline, 6 months, and 12 months postoperatively. Primary outcomes were breast appearance satisfaction (BREAST-Q), pain intensity (Numerical Rating Scale), and upper extremity function (Quick-DASH). Secondary outcome was health-related quality of life (SF-36). Linear mixed models analyzed changes over time with Bonferroni-adjusted pairwise comparisons. Mean age was 35.67 ± 8.42 years. Surgical procedures included wide local excision (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.